3 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Daliresp (Roflumilast ... /LABA/ICS) - ... /LABA) & Eosinophils ... GOLD guidelines ... /ambcarerx #Daliresp
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
symptoms, and spirometry ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... Diagnosis #Management #ACOPD ... #Differences #Algorithm
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... LAMA: long-acting ... muscarinic antagonist; LABA ... Management #Pulmonary #COPD ... #LABA #ICS #Guidelines